Robotic-assisted radical cystectomy: the first multicentric Brazilian experience
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGERNATURE
Autores
MOSCHOVAS, Marcio Covas
ARAP, Marco Antonio
TANURE, Luiz Henrique Rodrigues
BISTACCO, Carolina
Citação
JOURNAL OF ROBOTIC SURGERY, v.14, n.5, p.703-708, 2020
Resumo
The objective of this study is to report the first multicentric Brazilian series and learning curve of robotic radical cystectomy (RARC) with related intra- and postoperative outcomes. We retrospectively analyzed 37 RARC prospectively collected at four different centers in Brazil, from 2013 to 2019. We analyzed the patient's demographics, pathological tumor, and nodal status, as well as intra- and postoperative outcomes. Statistical analysis was performed with the IBM (SPSS version 25) software. Overall, 86% were male, and the median age was 69 years. 83% had muscle-invasive bladder cancer, and 17% a high-grade, recurrent non-muscle-invasive tumor. The median operative time was 420 min with 300 min as console time. Median blood loss was 350 ml and transfusion rate was 10%. In 68% of the cases, we performed an intracorporeal Bricker urinary diversion, 24% intracorporeal neobladder, and 8% ureterostomy. Six patients (16%) had a Clavien 1-2, 8% had Clavien 3, 2.5% had a Clavien 4, and 5% had Clavien 5. The median length of hospital stay was 7 days. The final pathological exam pointed out pT0 in 16%, pT1 in 8%, pT2 in 32%, >= pT3 in 27%, and 16% pTis. 95% had negative surgical margins. The survival at 30, 90, and 180 days was 98%, 95%, and 95%, respectively. To our knowledge, this is the first multicentric series of RARC reporting the learning curve in Brazil; even if still representing a challenging procedure, RARC could be safely and effectively faced by experienced surgeons at centers with high volumes of robotic surgery.
Palavras-chave
Robotic surgery, Robotic-assisted radical cystectomy, Bladder cancer
Referências
- Abreu ALDC, 2014, INDIAN J UROL, V30, P300, DOI 10.4103/0970-1591.135673
- Ahmed K, 2014, EUR UROL, V65, P340, DOI 10.1016/j.eururo.2013.09.042
- Bochner BH, 2018, EUR UROL, V74, P465, DOI 10.1016/j.eururo.2018.04.030
- Bochner BH, 2015, EUR UROL, V67, P1042, DOI 10.1016/j.eururo.2014.11.043
- Brassetti A, 2018, BJU INT, V121, P752, DOI 10.1111/bju.14112
- Collins JW, 2016, EUR UROL, V70, P649, DOI 10.1016/j.eururo.2016.05.020
- de Carvalho PA, 2020, EUR UROL, V77, P628, DOI 10.1016/j.eururo.2018.07.003
- Hussein AA, 2017, BJU INT, V120, P695, DOI 10.1111/bju.13934
- Johar RS, 2013, EUR UROL, V64, P52, DOI 10.1016/j.eururo.2013.01.010
- Khan MS, 2016, EUR UROL, V69, P613, DOI 10.1016/j.eururo.2015.07.038
- Lobo N, 2018, ARAB J UROL, V16, P307, DOI 10.1016/j.aju.2018.01.006
- Neumaier MF, 2019, INT BRAZ J UROL, V45, P703, DOI [10.1590/S1677-5538.IBJU.2018.0704, 10.1590/s1677-5538.ibju.2018.0704]
- Nix J, 2010, EUR UROL, V57, P196, DOI 10.1016/j.eururo.2009.10.024
- Novara G, 2009, J UROLOGY, V182, P914, DOI 10.1016/j.juro.2009.05.032
- Parekh D, 2017, J UROLOGY, V197, pE918, DOI 10.1016/j.juro.2017.03.044
- Parekh DJ, 2018, LANCET, V391, P2525, DOI 10.1016/S0140-6736(18)30996-6
- Parekh DJ, 2013, J UROLOGY, V189, P474, DOI 10.1016/j.juro.2012.09.077
- Porreca A, 2020, J ROBOT SURG, V14, P261, DOI 10.1007/s11701-019-00977-4
- Pruthi RS, 2008, J ENDOUROL, V22, P2469, DOI 10.1089/end.2008.0320
- Raza SJ, 2015, EUR UROL, V68, P721, DOI 10.1016/j.eururo.2015.04.021
- Sathianathen NJ, 2019, J UROLOGY, V201, P715, DOI 10.1016/j.juro.2018.10.006
- Satkunasivam R, 2019, EUR UROL ONCOL, V2, P443, DOI 10.1016/j.euo.2018.10.008
- Wiklund NP, 2011, BJU INT, V107, P1514, DOI 10.1111/j.1464-410X.2011.10307.x
- Zamboni S, 2019, BJU INT, V124, P656, DOI 10.1111/bju.14791